The 89 references in paper K. Mukhin Yu., O. Pylaeva A., К. Мухин Ю., О. Пылаева А. (2017) “Формирование когнитивных и психических нарушений при эпилепсии: роль различных факторов, связанных с заболеванием и лечением (обзор литературы и описания клинических случаев) // THE FORMATION OF COGNITIVE AND MENTAL DISORDERS IN EPILEPSY: THE ROLE OF VARIOUS FACTORS ASSOCIATED WITH DISEASE AND TREATMENT (A REVIEW OF LITERATURE AND CASE REPORTS)” / spz:neicon:rjdn:y:2017:i:3:p:7-33

1
Воронкова К.В., Петрухин А.С., Пылаева О.А., Холин А.А. Рациональная антиэпилептическая фармакотерапия. М.: Бином, 2007. 275 с. [Voronkova K.V., Petrukhin A.S., Pylaeva O.A., Kholin A.A. Rational antiepileptic pharmacotherapy. Moscow: Binom, 2007. 275 p. (In Russ.)].
(check this in PDF content)
2
Зенков Л.Р. Бессудорожные эпилептические энцефалопатии с психиатрическими, коммуникативными и поведенческими расстройствами. Вестник эпилептологии 2004;2:7–11. [Zenkov L.R. Anxiety epileptic encephalopathy with psychiatric, communicative and behavioral disorders. Vestnik epileptologii = Bulletin of Epileptology 2004;2:7–11. (In Russ.)].
(check this in PDF content)
3
Иванова И.В., Мухин К.Ю., Пылаева О.А. и др. Мутации в гене ARX: клинические, электроэнцефалографические и нейровизуализационные особенности у 3 пациентов. Русский журнал детской неврологии 2017;12(4):58–67. [I.V. Ivanova, K.Yu. Mukhin, O.A. Pylaeva et al. Mutations in the ARX gene: clinical, electroencephalographic and neuroimaging features in 3 patients. Russkiy zhurnal detskoy nevrologii = Russian Journal of Child Neurology 2017;12(4):58–67. (In Russ.)].
(check this in PDF content)
4
Карлов В.А. Эпилепсия у детей и взрослых женщин и мужчин. М.: Медицина, 2010. 720 с. [Karlov V.A. Epilepsy in children and adult women and men. Мoscow: Meditsina, 2010. 720 p. (In Russ.)].
(check this in PDF content)
5
Мухин К.Ю. Когнитивная эпилептиформная дезинтеграция: дефиниция, диагностика, терапия. Русский журнал детской неврологии 2012;7(1):3–20. [Mukhin K.Yu. Cognitive epileptiform disintegration: definition, diagnosis, treatment. Russkiy zhurnal detskoy nevrologii = Russian Journal of Child Neurology 2012;7(1):3–20. (In Russ.)].
(check this in PDF content)
6
Мухин К.Ю. Синдром Ландау–Клеффнера (приобретенная эпилептическая афазия) с фокусом на электроэнцефалографические критерии. Русский журнал детской неврологии 2016;11(3): 8–21. [Mukhin K.Yu. Landau–Kleffner syndrome (acquired epileptic aphasia) with focus on electroencephalographic criteria. Russkiy zhurnal detskoy nevrologii = Russian Journal of Child Neurology 2016;11(3):8–21. (In Russ.)].
(check this in PDF content)
7
Мухин К.Ю. Фокальные кортикальные дисплазии: клинико-электро-нейровизуализационные характеристики. Русский журнал детской неврологии 2016;11(2):8–24. [Mukhin K.Yu. Focal cortical dysplasia: clinical-electroneuroimaging characteristics. Russkiy zhurnal detskoy nevrologii = Russian Journal of Child Neurology 2016;11(2): 8–24. (In Russ.)].
(check this in PDF content)
8
Мухин К.Ю., Глухова Л.Ю. Эпилепсия с электрическим эпилептическим статусом в фазу медленного сна с фокусом на электроэнцефалографические критерии. Русский журнал детской неврологии 2017;12(2):21–35. [Mukhin K.Yu., Glukhova L.Yu. Epilepsy with electrical epileptic status in the phase of slow-wave sleep with focus on electroencephalographic criteria. Russkiy zhurnal detskoy nevrologii = Russian Journal of Child Neurology 2017;12(2):21–35. (In Russ.)].
(check this in PDF content)
9
Мухин К.Ю., Головтеев А.Л. Приобретенный эпилептический лобный синдром. Русский журнал детской неврологии 2008;3(1):21–9. [Mukhin K.Yu., Golovteev A.L. Acquired epileptic frontal syndrome. Russkiy zhurnal detskoy nevrologii = Russian Journal of Child Neurology 2008;3(1):21–9. (In Russ.)].
(check this in PDF content)
10
Мухин К.Ю., Миронов М.Б., Тысячина М.Д. и др. Электроклиническая характеристика больных симптоматической фокальной эпилепсией с феноменом вторичной билатеральной синхронизации на электроэнцефалограмме. Русский журнал детской неврологии 2006;1(1):6–17. [Mukhin K.Yu., Mironov M.B., Tysiachina M.D. Electroclinical characteristics of patients with symptomatic focal epilepsy with the phenomenon of secondary bilateral synchronization on the electroencephalogram. Russkiy zhurnal detskoy nevrologii = Russian Journal of Child Neurology 2006;1(1):6–17. (In Russ.)].
(check this in PDF content)
11
Мухин К.Ю., Пылаева О.А. Применение перампанела в лечении эпилепсии: обзор литературы и описание клиничес кого случая. Русский журнал детской неврологии 2016;11(2):52–62. [Mukhin K.Yu., Pylaeva O.A. Use of perampanel in the treatment of epilepsy: a review of literature and a case report. Russkiy zhurnal detskoy nevrologii = Russian Journal of Child Neurology 2016;11(2):52–62. (In Russ.)].
(check this in PDF content)
12
Пылаева О.А., Мухин К.Ю., Петрухин А.С. Побочные эффекты антиэпилептической терапии. М.: Гранат, 2016. 236 с. [Pylaeva O.A., Mukhin K.Yu., Petrukhin A.S. Side effects of antiepileptic therapy. Moscow: Granat, 2016. 236 p. (In Russ.)].
(check this in PDF content)
13
Эпилептология детского возраста: руководство для врачей. Под ред. А.С. Петрухина. М.: Медицина, 2000. 624 c. [Epileptology of childhood: a guide for doctors. Ed. A.S. Petrukhin. Moscow: Meditsina, 2000. 624 p. (In Russ.)].
(check this in PDF content)
14
Aldenkamp A., Besag F., Gobbi G. et al. Psychiatric and behavioural disorders in children with epilepsy (ILAE Task Force Report): adverse cognitive and behavioral effects of antiepileptic drugs in children. Epileptic Disord 2016 May 16. DOI: 10.1684/epd.2016.0817.
(check this in PDF content)
15
Alsaadi T., El Hammasi K., Shahrour T.M. et al. Prevalence of depression and anxiety among patients with epilepsy attending the epilepsy clinic at Sheikh Khalifa Medical City, UAE: a cross-sectional study. Epilepsy Behav 2015;52(Pt A):194–9. DOI: 10.1016/j.yebeh.2015.09.008.
(check this in PDF content)
16
Andersohn F., Schade R., Willich S.N. et al. Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology 2010;75(4):335–40. DOI: 10.1212/WNL.0b013e3181ea157e.
(check this in PDF content)
17
Arif H., Buchsbaum R., Weintraub D. et al. Patient-reported cognitive side effects of antiepileptic drugs: predictors and comparison of all commonly used antiepileptic drugs. Epilepsy Behav 2009;14(1):202–9. DOI: 10.1016/j. yebeh.2008.10.017.
(check this in PDF content)
18
Arzimanoglou A., Guerrini R., Aicardi J. Aicardi’s epilepsy in children. 3rd edn. Philadelphia: Lippincott, 2004. Pp. 176–87.
(check this in PDF content)
19
Aurich-Barrera B., Wilton L., Brown D. et al. Paediatric post-marketing pharmacovigilance: comparison of the adverse event profile of vigabatrin prescribed to children and adults. Pharmacoepidemiol Drug Saf 2011;20(6):608–18. DOI: 10.1002/ pds.2105.
(check this in PDF content)
20
Barabas G., Matthews W.S. Barbiturate anticonvulsants as a cause of severe depression. Pediatrics 1988;82(2):284–5. PMID: 3399308.
(check this in PDF content)
21
Ben-Menachem E., Scheepers B., Stodieck S. Epilepsy: from consensus to daily practice. Acta Neurologica Scandinavica 2003;108:5–15. PMID: 14510815.
(check this in PDF content)
22
Berg A.T. Epilepsy, cognition and behavior: the clinical picture epilepsia. Epilepsia 2011;52(suppl 1):7–12. DOI: 10.1111/j.1528-1167.2010.02905.x.
(check this in PDF content)
23
Besag F., Gobbi G., Aldenkamp A. et al. Behavioural and psychiatric disorders associated with epilepsy syndromes. In: Psychiatric and behavioural disorders in children with epilepsy. Eds.: F. Besag, A. Aldenkamp, R. Caplan et al. Montrouge: J.L. Eurotext, 2016. Pp. 46–62.
(check this in PDF content)
24
Boylan L.S., Flint L.A., Labovitz D.L. Depression but not seizure frequency predicts quality of in treatment-resistant epilepsy. Neurology 2004;62(2):258–61. PMID: 14745064.
(check this in PDF content)
25
Braun K.P. Preventing cognitive impairment in children with epilepsy. Curr Opin Neurol 2017;30(2):140–7. DOI: 10.1097/ WCO.0000000000000424.
(check this in PDF content)
26
Brent D.A., Crumrine P.K., Varma R. et al. Phenobarbital treatment and major depressive disorder in children with epilepsy. Pediatrics 1987;80(6):909–17. PMID: 3684404.
(check this in PDF content)
27
Calandre E.P., Dominguez-Granados R., Gomez-Rubio M. et al. Cognitive effects of long-term treatment with phenobarbital and valproic acid in school children. Acta Neur Scand 1990;81(6):504–6. PMID: 2220307.
(check this in PDF content)
28
Cook M., Shorvon S. The pharmacokinetics and clinical therapeutics of antiepileptic drugs. In: Oxford textbook of epilepsy and epileptic seizures. Oxford: Oxford university press, 2013. Pp. 279–289.
(check this in PDF content)
29
Craig I., Tallis R. Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind randomized comparative study. Epilepsia 1994;35(2):381–90. PMID: 8156961.
(check this in PDF content)
30
Cramer J.A., Hammer A.E., Kustra R.P. Improved mood states with lamotrigine in patients with epilepsy. Epilepsy Behav 2004;5(5):702–7. DOI: 10.1016/j. yebeh.2004.07.005.
(check this in PDF content)
31
Deonna Th., Roulet-Perez E. Mental retardation and epilepsy. In: Mental retardation. Eds.: D. Riva et al. Montrouge: J.L. Eurotext, 2007. Pp. 19–32.
(check this in PDF content)
32
Doose H. EEG in childhood epilepsy. Hamburg: John Libbey, 2003. Pp. 218–27.
(check this in PDF content)
33
Dulac O., Pinard J.-M., Plouin P. Infantile spasms associated with cortical dysplasia and tuberous sclerosis. In: Dysplasias of cerebral cortex and epilepsy. Eds.: R. Guerrini, F. Andermann, R. Canapicchi et al. Philadelphia: Lippincott Raven Publishers, 1996. Pp. 217–225.
(check this in PDF content)
34
Ettinger A.B., LoPresti A., Yang H. et al. Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel. Epilepsia 2015;56(8): 1252–63. DOI: 10.1111/epi.13054.
(check this in PDF content)
35
Fiest K.M., Dykeman J., Patten S.B. et al. Depression in epilepsy: a systematic review and meta-analysis. Neurology 2013;80(6):590–9. DOI: 10.1212/ WNL.0b013e31827b1ae0.
(check this in PDF content)
36
Fisher R.S., Acevedo C., Arzimanoglou A. et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014;55(4):475–82. DOI: 10.1111/ epi.12550.
(check this in PDF content)
37
Galanopoulou A.S., Bojko A., Lado F., Moshe S.L. The spectrum of neuropsychiatric abnormalities associated with electrical status epilepticus in sleep. Brain Dev 2000;22(5):279–95. PMID: 10891635.
(check this in PDF content)
38
Gallassi R., Morreale A., Di Sarro R. et al. Cognitive effects of antiepileptic drug discontinuation. Epilepsia 1992;33(suppl 6): 41–4. PMID: 1486836.
(check this in PDF content)
39
Grevers E., Breuer L.E., Ijff D.M., Aldenkamp A. Mental slowing in relation to epilepsy and antiepileptic medication. Acta Neurol Scand 2016;134(2):116–22. DOI: 10.1111/ane.12517.
(check this in PDF content)
40
Harbord M.G. Significant anticonvulsant side-effects in children and adolescents. J Clin Neurosci 2000;7(3):213–6. DOI: 10.1054/jocn.1999.0190.
(check this in PDF content)
41
Hirashima Y., Morimoto M., Nishimura A. et al. Alternative psychosis and dysgraphia accompanied by forced normalization in a girl with occipital lobe epilepsy. Epilepsy Behav 2008;12(3):481–5. DOI: 10.1016/j.yebeh.2007.11.002.
(check this in PDF content)
42
Holmes G.L. Effect of seizures on the developing brain and cognition. Semin Pediatr Neurol 2016;23(2):120–6. DOI: 10.1016/j.spen.2016.05.001.
(check this in PDF content)
43
Holthausen H., Fogarasi A., Arzimanoglou A., Kahane Ph. Structural (symptomatic) focal epilepsies of childhood. In: Epileptic syndromes in infancy, childhood and adolescence. Eds.: M. Bureau, P. Genton, C. Dravet et al. 5th edn. Paris: John Libbey Eurotext, 2012. Pp. 455–505.
(check this in PDF content)
44
Ibrahim G.M., Cassel D., Morgan B.R. et al. Resilience of developing brain networks to interictal epileptiform discharges is associated with cognitive outcome. Brain 2014;137(Pt 10):2690– 702. DOI: 10.1093/brain/awu214.
(check this in PDF content)
45
Ijff D.M., Aldenkamp A. Cognitive side effects of antiepileptic drugs in children. Handb Clin Neurol 2013;111:707–18. DOI: 10.1016/B978-0-444-528919.00073-7.
(check this in PDF content)
46
Ijff D.M., van Veenendaal T.M., Debeij van Hall M.H. et al. The cognitive profile of ethosuximide in children. Paediatr Drugs 2016;18(5):379–85. DOI: 10.1007/ s40272-016-0187-z.
(check this in PDF content)
47
Jaimes-Bautista A.G., Rodriguez-Camacho M., Martinez-Juarez I.E., Rodriguez-Agudelo Y. Quantitative and qualitative analysis of semantic verbal fluency in patients with temporal lobe epilepsy. Neurologia 2017;S0213-4853(17) 30235–9. DOI: 10.1016/j.nrl.2017.07.001.
(check this in PDF content)
48
Josephson C.B., Jette N. Psychiatric comorbidities in epilepsy. Int Rev Psychiatry 2017;29(5):409–24. DOI: 10.1080/09540261.2017.1302412.
(check this in PDF content)
49
Kalinin V.V. Suicidality and antiepileptic drugs: is there a link? Drug Saf 2007;30(2):123–42. PMID: 17253878.
(check this in PDF content)
50
Kaufman K.R., Struck P.J. Activation of suicidal ideation with adjunctive rufinamide in bipolar disorder. Epilepsy Behav 2011;20(2):386–9. DOI: 10.1016/j.yebeh.2010.11.014.
(check this in PDF content)
51
Kleffner F.R., Landau W.M. The Landau– Kleffner syndrome. Epilepsia 2009;50(suppl 7):3. DOI: 10.1111/j.1528-1167.2009.02208.x.
(check this in PDF content)
52
Korman B., Krsek P., Duchowny M. et al. Early seizure onset and dysplastic lesion extent independently disrupt cognitive networks. Neurology 2013;81(8):745–51. DOI: 10.1212/WNL.0b013e3182a1aa2a.
(check this in PDF content)
53
Levinson D.F., Devinsky O. Psychiatric adverse events during vigabatrin therapy. Neurology 1999;53(7):1503–11. PMID: 10534259.
(check this in PDF content)
54
Machado R.A., Espinosa A.G., Melendrez D. et al. Suicidal risk and suicide attempts in people treated with antiepileptic drugs for epilepsy. Seizure 2011;20(4):280–4. DOI: 10.1016/j.seizure.2010.12.010.
(check this in PDF content)
55
Mastrangelo M. Lennox–Gastaut syndrome: a state of the art review. Neuropediatrics 2017;48(3):143–51. DOI: 10.1055/s-0037-1601324.
(check this in PDF content)
56
Meador K. Neurodevelopmental impact of antiepileptic drugs. In: Neuropsychology in the care of people with epilepsy. Eds.: Ch. Helmstaedter et al. UK: J.L. Eurotext, 2011. Pp. 179–87.
(check this in PDF content)
57
Miller L.A., Galioto R., Tremont G. et al. Cognitive impairment in older adults with epilepsy: characterization and risk factor analysis. Epilepsy Behav 2016;56:113–7. DOI: 10.1016/j.yebeh.2016.01.011.
(check this in PDF content)
58
Moavero R., Santarone M.E., Galasso C., Curatolo P. Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy. Brain Dev 2017;39(6):464–69. DOI: 10.1016/j. braindev.2017.01.006.
(check this in PDF content)
59
Mula M., Sander J.W. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf 2007;30(7): 555–67. PMID: 17604407.
(check this in PDF content)
60
Nass R., Gross A., Devinsky O. Autism and autistic epileptiform regression with occipital spikes. Dev Med Child Neurol 1998;40(7):453–8. PMID: 9698058.
(check this in PDF content)
61
Olesen J.B., Hansen P.R., Erdal J. et al. Antiepileptic drugs and risk of suicide: a nationwide study. Pharmacoepidemiol Drug Saf 2010;19(5):518–24. DOI: 10.1002/pds.1932.
(check this in PDF content)
62
Overwater I.E., Verhaar B.J.H., Lingsma H.F. et al. Interdependence of clinical factors predicting cognition in children with tuberous sclerosis complex. J Neurol 2017;264(1): 161–7. DOI: 10.1007/s00415-016-8335-5.
(check this in PDF content)
63
Panayiotopoulos C.P. A clinical guide to epileptic syndromes and their treatment. 2nd edn. London: Springer, 2010. Pp. 45–49, 325–335.
(check this in PDF content)
64
Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 2002;16(10):695–724. PMID: 12269862.
(check this in PDF content)
65
Poindexter A.R., Kolstoe P.D. Effects of barbiturate withdrawal on behavior. Results from a barbiturate discontinuation program. Habilitative Mental Healthcare Newsletter 1998;11:63–70.
(check this in PDF content)
66
Prevey M.L., Delaney R.C., Cramer J.A. et al. Effect of valproate on cognitive function. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group. Arch Neurol 1996;53(10):1008–16. PMID: 8859063.
(check this in PDF content)
67
Reilly C., Atkinson P., Krishna B.D. et al. Neurobehavioral comorbidities in children with active epilepsy: a population-based study. Pediatrics 2014;133(6):1586–93. DOI: 10.1542/peds.2013-3787.
(check this in PDF content)
68
Rohracher A., Brigo F., Hofler J. et al. Perampanel for the treatment of primary generalized tonic-clonic seizures in idiopathic generalized epilepsy. Expert Opin Pharmacother 2016;17(10):1403–11. DOI: 10.1080/14656566.2016.1195810.
(check this in PDF content)
69
Rugg-Gunn F. Adverse effects and safety profile of perampanel: a review of pooled data. Epilepsia 2014;55(suppl 1):13–5. DOI: 10.1111/epi.12504.
(check this in PDF content)
70
Sabers A., Moller A., Dam M. et al. Cognitive function and anticonvulsant therapy: effect of monotherapy in epilepsy. Acta Neurol Scand 1995;92(1):19–27. PMID: 7572056.
(check this in PDF content)
71
Sanchez-Fernandez I.S., Loddenkemper T. Continuous spike-and-wave during sleep including Landau–Kleffner syndrome. In: Wyllie’s treatment of epilepsy. Principles and practice. Ed. E. Wyllie. Philadelphia: Wolters Kluwer, 2015. Pp. 284–292.
(check this in PDF content)
72
Sankar R., Holmes G.L. Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects. J Child Neurol 2004;19(suppl 1):6– 14. DOI: 10.1177/088307380401900102.
(check this in PDF content)
73
Scheffer I.E., Berkovic S., Capovilla G. et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017;58(4):512–21. DOI: 10.1111/ epi.13709.
(check this in PDF content)
74
Schoenberg M.R., Rum R.S., Osborn K.E., We r z M . A . A r a n d o m i z e d , d o u b l e - b l i n d , p l acebo-controlled crossover study of the effects of levetiracetam on cognition, mood and balance in healthy older adults. Epilepsia 2017; 58(9):1566–74. DOI: 10.1111/epi.13849.
(check this in PDF content)
75
Schubert R. Attention deficit disorder and epilepsy. Pediatr Neurol 2005;32(1):1–10. DOI: 10.1016/j.pediatrneurol.2004.06.007.
(check this in PDF content)
76
Straussberg R., Kivity S., Weitz R. et al. Reversible cortical atrophy and cognitive decline induced by valproic acid. Eur J Paediatr Neurol 1998;2(4):213–8. PMID: 10726594.
(check this in PDF content)
77
Swaiman K.F., Ashwal S., Ferriero D.M. et al. Swaiman’s pediatric neurology. Principles and practice. 6th edn. Philadelphia: Elsevier, 2017. 2969 p.
(check this in PDF content)
78
Tassinari C.A., Cantaluppo G., Dalla Bernardina B. et al. Encephalopathy related to status epilepticus during slow sleep (ESES) including Landau–Kleffner syndrome. In: Epileptic syndromes in infancy, childhood and adolescence. Eds.: M. Bureau, P. Genton, C. Dravet et al. 5th edn. Paris: John Libbey Eurotext, 2012. Pp. 255–75.
(check this in PDF content)
79
Thompson P.J., Huppert F.A., Trimble M.R. Phenytoin and cognitive functions: effects on normal volunteers and implications for epilepsy. British Journ Clin Psychol 1981;20(Pt 3):155–62. PMID: 7284649.
(check this in PDF content)
80
Thompson P.J., Huppert F., Trimble M.R. Anticonvulsant drugs, cognitive function and memory. Acta Neurol Scand 1980;80:75–81. PMID: 6937084.
(check this in PDF content)
81
Thompson P.J., Trimble M.R. Sodium valproate en cognitive functioning in normal volunteers. Br J Clin Pharmacol 1981;12(6):819–24. PMID: 6803819.
(check this in PDF content)
82
Trimble M.R., Schmitz B. Seizures, affective disorders and anticonvulsant drugs. Guildford: Clarus Press Ltd., 2002. 199 p.
(check this in PDF content)
83
Bogaert P. Epileptic encephalopathy with continious spike–waves during slowwave sleep including Landau–Kleffner syndrome: what determines the outcome? In: Outcome of childhood epilepsies. Eds.: W.F. Arts, A. Arzimanoglou, O.F. Brouwer, C. Camfield, P. Camfield. Montrouge: J.L. Eurotext, 2013. Pp. 141–148.
(check this in PDF content)
84
Veenendaal T.M., Ijff D.M., Aldenkamp A. et al. Glutamate concentrations vary with antiepileptic drug use and mental slowing. Epilepsy Behav 2016; 64(Pt A):200–5. DOI: 10.1016/j.yebeh.2016.08.027.
(check this in PDF content)
85
Vining E.P. Use of barbiturates and benzodiazepines in treatment of epilepsy. Neurol Clin 1986;4(3):617–32. PMID: 3528811.
(check this in PDF content)
86
Vinten J., Bromley R.L., Taylor J. et al. The behavioral consequences of exposure to antiepileptic drugs in utero. Epilepsy Behav 2009;14(1):197–201. DOI: 10.1016/j.yebeh.2008.10.011.
(check this in PDF content)
87
Williams A.E., Giust J.M., Kronenberger W.G., Dunn D.W. Epilepsy and attention-deficit hyperactivity disorder: links, risks and challenges. Neuropsychiatr Dis Treat 2016;12:287–96. DOI: 10.2147/NDT.S81549.
(check this in PDF content)
88
Witt J.-A., Helmstaedter Ch. Assessing cognitive antiepileptic drug effects in the individual patient. In: Neuropsychology in the care of people with epilepsy. Eds.: Ch. Helmstaedter et al. UK: J.L. Eurotext, 2011. Pp. 163–177.
(check this in PDF content)
89
Witt J.A., Elger C.E., Helmstaedter C. Impaired verbal fluency under topiramate – evidence for synergistic negative effects of epilepsy, topiramate and polytherapy. Eur J Neurol 2013;20(1):130–7.
(check this in PDF content)